Table 2.
Age, yrs | 53 (48–57) |
Male/female | 9 (39.1%)/14 (60.9%) |
Race, Caucasian/African American | 10 (43.5%)/13 (56.5%) |
Major comorbidities | |
Diabetes mellitus | 16 (69.6%) |
Coronary artery diseases | 8 (34.8%) |
Hypertension | 21 (91.3%) |
Dyslipidemia | 14 (60.9%) |
Obesity grading | |
Grade I obesity, BMI ≥30 and <35 kg/m2 | 1 (4.4%) |
Grade II obesity, BMI ≥35 and <40 kg/m2 | 6 (26.1%) |
Grade III or severe obesity, BMI ≥40 kg/m2 | 16 (69.6%) |
Major dietary characteristics | |
Total daily energy, kcal | 2,066 (1,897–2,642) |
Fat, % of total energy | 38.3 (29.7–45.6) |
Monounsaturated fatty acids, % of total energy | 13.8 (10.9–15.3) |
Polyunsaturated fatty acids, % of total energy | 8.6 (7.4–11.9) |
Saturated fatty acids, % of total energy | 12.7 (9.4–15.5) |
Carbohydrates, % of total energy | 47.7 (38.4–56.8) |
Sugars, % of total energy | 20.3 (14.4–29.8) |
Protein, % of total energy | 14.1 (12.7–16.1) |
Sodium, mg | 3,252 (2,578–3946) |
Cholesterol, mg | 248.1 (200.9–476.3) |
Body mass and composition | |
BMI, kg/m2 | 42.4 (35.2–44.4) |
Fat mass, kg | 54.8 (49.7–59.6) |
Fat mass index, kg/m2 | 18.8 (16.8–21.3) |
Fat-free mass, kg | 70.4 (61.0–83.4) |
Fat-free mass index, kg/m2 | 24.0 (21.6–27.7) |
Functional capacity | |
Exercise time, min | 8.5 (7.5–9.8) |
Respiratory exchange ratio | 1.13 (1.04–1.17) |
Peak oxygen consumption, ml · kg−1 · min−1 | 14.4 (11.8–18.5) |
Oxygen uptake efficiency (slope) | 2.2 (1.9–2.5) |
Peak oxygen pulse, ml · min−1 | 14.8 (13.2–17.1) |
Doppler echocardiographic parameters | |
Left ventricular ejection fraction, % | 60.4 (57.1–63.0) |
Stroke volume, ml | 67.2 (57.9–75.6) |
E′ velocity, cm/s | 8.0 (6.2–8.4) |
E/E′ ratio | 12.1 (10.1–15.3) |
E/A ratio | 1.1 (1.0–1.3) |
DT, ms | 241.0 (195.8–278.1) |
E′/DT ratio | 0.33 (0.26–0.41) |
Biomarkers | |
NT-proBNP, pg/ml | 90 (47–242) |
Estimated glomerular filtration rate, ml/min/1.73 m2 | 68 (52–85) |
Values are median (interquartile range) or n (%).
BMI = body mass index; DT = deceleration time; NT-proBNP = N-terminal pro–brain natriuretic peptide.